We are live on
!
Find out more
KYNB
Kyntra Bio
KYNB
KYNB
133 hedge funds and large institutions have $632M invested in Kyntra Bio in 2016 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 48 increasing their positions, 42 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
41% more call options, than puts
Call options by funds: $3.24M | Put options by funds: $2.29M
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
22% more capital invested
Capital invested by funds: $518M → $632M (+$113M)
14% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 42
9% less funds holding
Funds holding: 146 → 133 (-13)
48% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 23
Holders
133
Holders Change
-13
Holders Change %
-8.9%
% of All Funds
3.55%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.11%
New
12
Increased
48
Reduced
42
Closed
23
Calls
$3.24M
Puts
$2.29M
Net Calls
+$945K
Net Calls Change
+$1.5M
Top Buyers
Top Sellers
| 1 |
Goldman Sachs
New York
|
-$12.8M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$6.49M |
| 3 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
-$4.65M |
| 4 |
JP Morgan Chase
New York
|
-$3.88M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$3.77M |
